Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Operating Expenses (2017 - 2025)

Historic Operating Expenses for MedWellAI (MWAI) over the last 11 years, with Q3 2025 value amounting to $422128.0.

  • MedWellAI's Operating Expenses fell 2846.89% to $422128.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 68962.16%. This contributed to the annual value of $3.4 million for FY2025, which is 6212.72% down from last year.
  • According to the latest figures from Q3 2025, MedWellAI's Operating Expenses is $422128.0, which was down 2846.89% from $106678.0 recorded in Q2 2025.
  • In the past 5 years, MedWellAI's Operating Expenses registered a high of $23.6 million during Q2 2023, and its lowest value of -$4.8 million during Q2 2024.
  • Moreover, its 5-year median value for Operating Expenses was $924242.0 (2022), whereas its average is $3.5 million.
  • As far as peak fluctuations go, MedWellAI's Operating Expenses skyrocketed by 803698.93% in 2021, and later crashed by 12023.22% in 2024.
  • Over the past 5 years, MedWellAI's Operating Expenses (Quarter) stood at $2.1 million in 2021, then tumbled by 85.39% to $302251.0 in 2022, then skyrocketed by 582.81% to $2.1 million in 2023, then tumbled by 58.35% to $859523.0 in 2024, then tumbled by 50.89% to $422128.0 in 2025.
  • Its last three reported values are $422128.0 in Q3 2025, $106678.0 for Q2 2025, and $1.3 million during Q1 2025.